GIP analogues have also shown neuroprotective effects in animal models of AD and Parkinson's disease (Duffy & Hoelscher, 2013; Faivre & Hoelscher, 2013; Li, Liu, Li, & Hoelscher, 2016; Li, Liu, Li, & Holscher, 2017). Here, GIP is linked to Alzheimer disease.